Contents
Key details of the ICICI Prudential Nifty Pharma ETF NFO
| Fund house | ICICI Prudential Mutual Fund |
|---|---|
| Category (AMFI) | Exchange Traded Funds (ETFs) - Other ETF |
| Scheme type | Open Ended |
| NFO opens | 12 October 2026 |
| NFO closes | 19 October 2026 |
| After the NFO | Units list on BSE and NSE within 5 business days of allotment. |
| Offer price | ₹10 a unit |
| Minimum investment | ₹1,000 |
| Exit load | There will be no exit load for units sold through the secondary market on the stock exchanges where the Scheme will be listed. Currently, the Scheme is proposed to be listed on BSE and NSE. Investors shall note that the brokerage on sales of the units of the scheme on the stock exchanges shall be borne by the investors. However, during the process of creation/ redemption there may be transaction costs & /or other incidental expenses(forming part of the Cash Compon |
| Benchmark | Nifty Pharma TRI |
| Fund managers | Nishit Patel, Ashwini Bharucha and Venus Ahuja |
| Maximum expense ratio | Up to 0.90% a year, before taxes and levies |
| Scheme information document | Read on AMFI (PDF) |
What ICICI Prudential Nifty Pharma ETF will invest in
The scheme information document states the objective as: “The objective of the investment scheme is to provide returns before expenses that closely correspond to the total return of the underlying index, subject to tracking errors.”
How it compares with existing Nifty Pharma index funds and ETFs
- 1 index fund and 1 ETF already track the Nifty Pharma, according to AMFI's NAV list.
- Over the past one year to 16 October 2026, the 2 with that long a record returned between 16.8% and 17.1%.
- Over the past three years to 16 October 2026, the 2 with that long a record returned between 19.4% and 19.8% a year.
- Funds on the same index hold the same shares, so the gaps between them come mainly from expense ratios and tracking error.
| Period | Funds | Lowest | Median | Highest |
|---|---|---|---|---|
| 1 year | 2 | 16.8% | 16.9% | 17.1% |
| 3 years (per year) | 2 | 19.4% | 19.6% | 19.8% |
Index funds use Direct-Growth plans; ETFs count once each. Returns are from AMFI daily NAVs, annualised for three years, and leave out figures distorted by unit splits.
Other funds’ returns do not tell you how this fund will do. They show what the category or index has delivered and how far results have varied between funds.
What to check before investing in this NFO
- The ₹10 price is not a discount. Units start at ₹10 only to set the unit count. Returns depend on how the fund's investments move, in percentage terms, exactly as for an existing fund.
- Cost and tracking error decide the difference. Every fund on the same index holds the same shares, so the fund with the lower expense ratio and the smaller tracking error usually delivers more. A new fund's tracking error is unknown until it has run for a while; existing Nifty Pharma index funds and ETFs already have a record.
- Overlap with what you already own. If you already hold a fund on the same or a broader index, a new one may add little: the underlying shares can be largely the same.
- Direct plan and costs. The direct plan pays no distributor commission, so its expense ratio is lower than the regular plan’s. Over many years the difference compounds.
- Buying and selling after listing. After the NFO, ETF units trade on the stock exchange, so you need a demat account. Check trading volumes and how close the market price stays to the NAV.
After the NFO closes
Units are allotted after the offer closes. The ETF then lists on the stock exchange, where its units trade during market hours. Units list on BSE and NSE within 5 business days of allotment.
Once a fund has a record, Genvest Research shows its returns against its benchmark, volatility and drawdowns.
Questions people ask
The NFO closed on 19 October 2026. After it reopens, you can invest at the daily NAV like any other open-ended fund.
The minimum is ₹1,000 during the NFO, according to AMFI's listing. Units are offered at ₹10 each.
No. The ₹10 starting price only sets the unit count. What you earn depends on the percentage change in the fund's investments, which is the same whether a unit costs ₹10 or ₹500.
There will be no exit load for units sold through the secondary market on the stock exchanges where the Scheme will be listed. Currently, the Scheme is proposed to be listed on BSE and NSE. Investors shall note that the brokerage on sales of the units of the scheme on the stock exchanges shall be borne by the investors. However, during the process of creation/ redemption there may be transaction costs & /or other incidental expenses(forming part of the Cash Compon.
The scheme information document names Nifty Pharma TRI as the benchmark.
The scheme information document names Nishit Patel, Ashwini Bharucha and Venus Ahuja as the fund managers.
That depends on what you already own and why you would add this fund. A new fund has no record of its own, so compare it with existing Nifty Pharma index funds and ETFs: their costs, their returns over several years and how much they overlap with funds you hold. This page explains the facts; it is not a recommendation.
Other NFOs open now
| Fund | Type | Closes | Minimum | Existing funds |
|---|---|---|---|---|
| Axis Nifty EV & New Age Automotive Index FundAxis | Index fund · Nifty EV & New Age Automotive | 30 OctCloses tomorrow | ₹100 | 2 on the same index |
| Carnelian Small Cap FundCarnelian | Small cap | 30 OctCloses tomorrow | ₹500 | 36 in the category |
| ICICI Prudential BSE Power ETFICICI Prudential | ETF · BSE Power | 30 OctCloses tomorrow | ₹1,000 | 1 on the same index |
| Samco Equity Savings FundSamco | Equity savings | 2 NovCloses in 4 days | ₹5,000 | 22 in the category |
| UTI Financial Services Debt FundUTI | Sectoral debt | 2 NovCloses in 4 days | ₹500 | 2 in the category |
| Choice Large & Mid Cap FundChoice | Large & mid cap | 3 NovCloses in 5 days | ₹1,000 | 36 in the category |
| Motilal Oswal Multi Asset Omni Fund of FundsMotilal Oswal | Fund of funds | 4 NovCloses in 6 days | ₹500 | – |
| Navi Multi Asset Omni FoFNavi | Fund of funds | 4 NovCloses in 6 days | ₹100 | – |
Sources
- AMFI new fund offer list.
- ICICI Prudential Nifty Pharma ETF scheme information document.
- AMFI daily NAVs to 16 Oct, for existing funds.
This page is educational research based on AMFI data and scheme information documents. It is not a recommendation to invest in any scheme, or personalised investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past performance of other funds does not indicate how a new fund will perform. Registration granted by SEBI, enlistment with IAASB and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.